Login · Contact

Akorn Pharmaceuticals

Akorn Investor Relations
Press Release
Printer Friendly Version View printer-friendly version
<< Back
Akorn to Present at 35th Annual J.P Morgan Healthcare Conference

LAKE FOREST, Ill., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn’s CEO, Raj Rai, will present at the 35th Annual J.P. Morgan Healthcare Conference.

Event: J.P. Morgan Healthcare Conference
Date: January 9, 2017
Time: 4:30 PM PT
Location: San Francisco, California

The presentation will be webcast live and available on the “Events & Presentations” page in the Investor Relations section of the Company’s website at investors.akorn.com.  A replay will be posted on the Akorn website approximately one hour after the live events and will be available for 30 days following the presentations.

About Akorn, Inc. 
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; Hettlingen, Switzerland and Paonta Sahib, India that manufacture ophthalmic, injectable and specialty sterile and non-sterile pharmaceuticals. Additional information is available on Akorn’s website at www.akorn.com.

Investors/Media:
Stephanie Carrington
ICR, Inc.
(646) 277-1282
Stephanie.carrington@icrinc.com

Primary Logo

Akorn, Inc.